The move would help the Haridwar-based firm access a global marketing platform, as Patanjali is focusing on exports for its Ayurveda-based FMCG products.
The Madras HC was hearing a suit filed by a Chennai firm which claimed it owned the 'Coronil' trademark since 1993. The court also noted Patanjali's drug was not a Covid cure.
Since 29 June, stock has consistently fallen by 5% for 6 consecutive days, triggering lower circuit — levels where trading activity in a stock are suspended following a sharp fall in share prices.
Ramdev said AYUSH ministry has used the term ‘Covid management’ for Patanjali's Coronil kit, but govt letter doesn’t clarify what it means by ‘management’.
The 17-member taskforce also suggested Patanjali should sell medicines for cough, fever & immunity-boosting as these are the conditions for which it had sought approval.
The reaction to Ramdev’s launch of Coronil, which claims to be a ‘cure’ for Covid-19, would be a nightmare for any other company. Not Patanjali, though.
Even as Modi govt asked Patanjali to stop advertising Coronil as a Covid 'cure', platforms did little to stop misleading hashtags, or remove health misinformation.
Rajasthan govt had clarified that the drug cannot be not used as a medicine without the permission of AYUSH Ministry. The notice was served to NIMS Hospital.
Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.
Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.
21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS